LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-Edge Biotech Solutions Fate Therapeutics is a pioneering biopharmaceutical company specializing in induced pluripotent stem cell (iPSC)-derived cellular immunotherapies for cancer and autoimmune diseases. Their innovative product pipeline, including engineered NK and T-cell candidates with chimeric antigen receptors, presents lucrative opportunities for partnerships and collaborations in the biotechnology sector.

Investment Potential Recent financial activities showcase investor confidence in Fate Therapeutics, indicating potential growth and scalability. The company's ability to secure investments, such as the $91,000 from Aigen Investment Management LP, positions them as a promising prospect for investors seeking opportunities in the biotech industry.

Expanding Preclinical Data Fate Therapeutics' presentation of preclinical data for autoimmune diseases with FT522 at the ASGCT Annual Meeting signals advancements in therapeutic development. This breakthrough in research opens avenues for partnerships with healthcare institutions and pharmaceutical companies looking to invest in cutting-edge treatment solutions.

Senior Leadership Transition The recent departure of Edward Dulac as Chief Financial Officer may indicate a need for strategic partnerships or vendor relationships to support financial functions. This leadership change presents an opportunity for financial service providers or consulting firms to engage with Fate Therapeutics during a crucial transition phase.

Competitive Positioning and Market Expansion Fate Therapeutics' commitment to developing innovative drugs and treatments for cancer and autoimmune diseases positions them as a formidable player in the biotechnology market. Collaborating with similar companies like BlueRock Therapeutics and Repligen Corporation can enhance market penetration and broaden sales opportunities by leveraging shared expertise and resources.

Similar companies to Fate Therapeutics Inc.

Fate Therapeutics Inc. Tech Stack

Fate Therapeutics Inc. uses 8 technology products and services including GitHub, MySQL, Zendesk, and more. Explore Fate Therapeutics Inc.'s tech stack below.

  • GitHub
    Communication And Collaboration
  • MySQL
    Database
  • Zendesk
    Documentation Tools
  • Microsoft Word
    Editors
  • web-vitals
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Amazon Web Services
    Platform As A Service
  • Adobe Tag Manager
    Tag Management

Media & News

Fate Therapeutics Inc.'s Email Address Formats

Fate Therapeutics Inc. uses at least 1 format(s):
Fate Therapeutics Inc. Email FormatsExamplePercentage
First.Last@fatetherapeutics.comJohn.Doe@fatetherapeutics.com
97%
F.Last@fatetherapeutics.comJ.Doe@fatetherapeutics.com
2%
FirstL@fatetherapeutics.comJohnD@fatetherapeutics.com
1%

Frequently Asked Questions

Where is Fate Therapeutics Inc.'s headquarters located?

Minus sign iconPlus sign icon
Fate Therapeutics Inc.'s main headquarters is located at 12278 Scripps Summit Dr San Diego, California 92131 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Fate Therapeutics Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Fate Therapeutics Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Fate Therapeutics Inc.'s stock symbol?

Minus sign iconPlus sign icon
Fate Therapeutics Inc. is a publicly traded company; the company's stock symbol is FATE.

What is Fate Therapeutics Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Fate Therapeutics Inc.'s official website is fatetherapeutics.com and has social profiles on LinkedIn.

How much revenue does Fate Therapeutics Inc. generate?

Minus sign iconPlus sign icon
As of August 2024, Fate Therapeutics Inc.'s annual revenue reached $35M.

What is Fate Therapeutics Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Fate Therapeutics Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 812930 - Parking Lots and Garages.

How many employees does Fate Therapeutics Inc. have currently?

Minus sign iconPlus sign icon
As of August 2024, Fate Therapeutics Inc. has approximately 239 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer: Y. C.Vice President Clinical Development, Head Of Autoimmunity: V. S.Head Of Ip, Assistant General Counsel: Y. C.. Explore Fate Therapeutics Inc.'s employee directory with LeadIQ.

What industry does Fate Therapeutics Inc. belong to?

Minus sign iconPlus sign icon
Fate Therapeutics Inc. operates in the Biotechnology Research industry.

What technology does Fate Therapeutics Inc. use?

Minus sign iconPlus sign icon
Fate Therapeutics Inc.'s tech stack includes GitHubMySQLZendeskMicrosoft Wordweb-vitalsjQueryAmazon Web ServicesAdobe Tag Manager.

What is Fate Therapeutics Inc.'s email format?

Minus sign iconPlus sign icon
Fate Therapeutics Inc.'s email format typically follows the pattern of . Find more Fate Therapeutics Inc. email formats with LeadIQ.

How much funding has Fate Therapeutics Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2024, Fate Therapeutics Inc. has raised $100M in funding. The last funding round occurred on Mar 19, 2024 for $100M.

When was Fate Therapeutics Inc. founded?

Minus sign iconPlus sign icon
Fate Therapeutics Inc. was founded in 2007.
Fate Therapeutics Inc.

Fate Therapeutics Inc.

Biotechnology ResearchCalifornia, United States201-500 Employees

Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company’s effector cell pipeline includes multiplexed-engineered, iPSC-derived natural killer (NK) cell and T-cell product candidates, which incorporate novel synthetic controls of cell function, such as chimeric antigen receptors (CARs) to target tumor-associated antigens and are intended to deliver multiple mechanisms of therapeutic importance to patients including in combination with well-established cancer therapies. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.

Section iconCompany Overview

Headquarters
12278 Scripps Summit Dr San Diego, California 92131 US
Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
FATE
NAICS Code
812930 - Parking Lots and Garages
Founded
2007
Employees
201-500

Section iconFunding & Financials

  • $100M

    Fate Therapeutics Inc. has raised a total of $100M of funding over 17 rounds. Their latest funding round was raised on Mar 19, 2024 in the amount of $100M.

  • $10M$50M

    Fate Therapeutics Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $100M

    Fate Therapeutics Inc. has raised a total of $100M of funding over 17 rounds. Their latest funding round was raised on Mar 19, 2024 in the amount of $100M.

  • $10M$50M

    Fate Therapeutics Inc.'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.